Investidor Profissional Gestao de Recursos Ltda. Purchases Shares of 721 Medpace Holdings, Inc. (NASDAQ:MEDP)

Investidor Profissional Gestao de Recursos Ltda. acquired a new position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 721 shares of the company’s stock, valued at approximately $240,000. Medpace comprises approximately 0.1% of Investidor Profissional Gestao de Recursos Ltda.’s investment portfolio, making the stock its 15th biggest holding.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MEDP. Vanguard Group Inc. raised its position in Medpace by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 2,570,770 shares of the company’s stock valued at $854,087,000 after purchasing an additional 25,704 shares during the last quarter. State Street Corp raised its holdings in shares of Medpace by 7.2% in the third quarter. State Street Corp now owns 752,957 shares of the company’s stock valued at $251,337,000 after buying an additional 50,312 shares during the last quarter. Geode Capital Management LLC lifted its position in Medpace by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 656,130 shares of the company’s stock worth $218,031,000 after buying an additional 28,076 shares in the last quarter. Wellington Management Group LLP grew its holdings in Medpace by 36.0% during the 3rd quarter. Wellington Management Group LLP now owns 415,255 shares of the company’s stock worth $138,612,000 after acquiring an additional 109,886 shares during the last quarter. Finally, GW&K Investment Management LLC increased its position in Medpace by 93.9% in the 4th quarter. GW&K Investment Management LLC now owns 275,460 shares of the company’s stock valued at $91,516,000 after acquiring an additional 133,379 shares in the last quarter. 77.98% of the stock is owned by institutional investors.

Medpace Trading Down 5.6 %

NASDAQ:MEDP opened at $287.11 on Friday. Medpace Holdings, Inc. has a 1-year low of $282.42 and a 1-year high of $459.77. The firm has a market capitalization of $8.75 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 3.81 and a beta of 1.45. The business’s 50-day moving average price is $331.56 and its two-hundred day moving average price is $337.60.

Medpace (NASDAQ:MEDP) last posted its earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. Sell-side analysts predict that Medpace Holdings, Inc. will post 12.29 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on MEDP. Leerink Partnrs upgraded shares of Medpace to a “hold” rating in a research report on Monday, March 24th. Leerink Partners initiated coverage on Medpace in a report on Monday, March 24th. They set a “market perform” rating and a $330.00 price objective on the stock. Finally, Robert W. Baird lifted their target price on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Nine equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $376.30.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.